Learn About Rexulti Costs Under Medicare

Understanding Rexulti and How Medicare Coverage Works

Rexulti (brexpiprazole) is a prescription medication used to treat certain mental health conditions, including depression and schizophrenia. Like many modern psychiatric medications, it's a brand-name drug that can represent a significant expense for people managing these conditions over months or years. Understanding how Medicare handles the cost of Rexulti involves learning about the different parts of Medicare coverage and how prescription drugs fit into each one.

Learn How to Pay Your GFLenv Bill Online →

Medicare is divided into different parts, each covering different types of medical services. Part A covers hospital stays, Part B covers doctor visits and outpatient services, and Part D specifically covers prescription medications. Because Rexulti is a prescription drug, your out-of-pocket costs depend largely on whether you have Part D coverage and which plan you've chosen. It's important to know that not all Medicare plans cover every drug in the same way, and your costs can vary significantly depending on your specific plan's formulary—the list of drugs your plan agrees to help pay for.

The actual price of Rexulti at the pharmacy can vary widely. The drug manufacturer sets a list price (called the "wholesale acquisition cost"), but this isn't what Medicare or patients typically pay. Instead, there's a negotiated price between Medicare, insurance companies, and pharmacies. As of recent years, Rexulti's list price is substantial—often ranging from $1,000 to $1,500 per month depending on the dosage and quantity prescribed. However, what you pay depends on multiple cost-sharing factors built into Medicare's drug benefit structure.

Takeaway: Rexulti's cost in the Medicare system depends on your coverage type and plan, not just the medication's list price. Learning about Part D and formularies gives you the foundation for understanding potential expenses.

How Medicare Part D Formularies Determine Your Rexulti Costs

Every Medicare Part D plan operates using a formulary—a curated list of medications the plan covers. Formularies are tiered systems, meaning drugs are placed into different cost categories, or "tiers." Understanding these tiers is crucial because they directly determine how much you'll pay out of pocket for Rexulti. Not every Part D plan includes Rexulti on their formulary, and among those that do, the tier placement varies.

How to Turn On Your Samsung Phone Flashlight →

Tier 1 typically includes generic medications with the lowest cost-sharing (copayments). Tier 2 includes preferred brand-name drugs with moderate copayments. Tier 3 includes non-preferred brand-name drugs with higher copayments. Tier 4 and Tier 5 are specialty tiers, sometimes reserved for the most expensive medications, requiring even higher copayments or coinsurance. Rexulti, being a brand-name medication without a generic equivalent (in most cases), typically falls into Tier 3 or higher on most formularies, though this varies by plan.

When a drug is placed in a higher tier, your copayment increases. For example, one Part D plan might charge a $50 copayment for Rexulti, while another plan might charge $75, $100, or even require you to pay a percentage of the cost (coinsurance). Some plans may require prior authorization, meaning your doctor must request approval before the medication is covered. Other plans might have step therapy requirements, where you try a lower-cost medication first before the plan will cover Rexulti.

The specific tier placement and coverage rules for Rexulti can change from year to year and between plans offered by different insurance companies. During Medicare's annual open enrollment period (October 15 through December 7 each year), plans may shift their formularies, move drugs to different tiers, or discontinue coverage altogether. This means the amount you paid for Rexulti last year might not be what you pay this year if you don't actively compare plans.

Takeaway: Formulary tier placement directly affects your Rexulti costs. Because tier placement changes annually and varies by plan, comparing your current plan's formulary with other available plans during open enrollment can reveal significant savings opportunities.

Cost-Sharing Stages and How They Impact Your Annual Rexulti Expenses

Medicare Part D prescription drug coverage operates through four distinct cost-sharing stages throughout each calendar year. Understanding how these stages work is essential for budgeting your medication expenses and predicting when Rexulti might become significantly more or less expensive depending on your total drug spending.

Learn How to Change Date Formats in Excel →

The first stage is called the "deductible stage." Each Part D plan has an annual deductible that you must pay out of pocket before your plan begins sharing costs with you. Not all Part D plans include a deductible—some have $0 deductibles—but when they do, deductibles typically range from $95 to several hundred dollars annually. During this stage, you pay the full negotiated price for Rexulti at the pharmacy. If your plan has a $100 deductible and Rexulti costs $120 per month, you would pay the full amount until your deductible is met.

Once you've met your deductible, you enter the "initial coverage stage." During this phase, your plan covers a percentage of your drug costs, and you pay the remaining portion through copayments or coinsurance. This is typically where most of your Rexulti use falls. A copayment is a fixed dollar amount (like $50 per prescription), while coinsurance is a percentage of the drug's cost (like 20%). Many people find this stage to be their most predictable cost period because they're paying a consistent amount per fill.

If your total drug spending (what both you and your plan pay) reaches a certain threshold, you enter the "coverage gap" or "donut hole." In 2024, this gap begins after combined spending reaches approximately $5,850. During the coverage gap, you pay a higher percentage of drug costs, though manufacturers' discounts and plan variations complicate this picture. For brand-name drugs like Rexulti, you typically pay about 25% of the cost during this stage, though this percentage has been changing in recent years to reduce out-of-pocket maximums.

The final stage is "catastrophic coverage," which begins once your out-of-pocket spending reaches your plan's maximum limit (around $7,050 in 2024). After this point, your plan covers the majority of costs, and you typically pay only a small copayment or coinsurance percentage. For someone taking Rexulti year-round, understanding when you'll reach catastrophic coverage can significantly impact financial planning.

Takeaway: Your Rexulti costs change throughout the year depending on which cost-sharing stage you're in. Tracking your spending against deductible and out-of-pocket maximums helps you predict when your costs will decrease or stabilize.

Manufacturer Discounts and Patient Assistance Programs Outside Medicare

Beyond Medicare's official structure, Rexulti's manufacturer (Otsuka Pharmaceutical) offers programs that may reduce your costs. These programs exist separately from Medicare and are worth exploring if you're struggling with out-of-pocket expenses. Understanding what's available can make a meaningful difference in your annual medication budget.

Free Guide to Filing Weekly Unemployment Claims Online →

Many pharmaceutical manufacturers operate patient assistance programs (PAPs) that provide discounts or free medication to people who meet income and other criteria. Otsuka offers programs that may help reduce copayments or provide medications at reduced costs to individuals with financial hardship. These programs typically have income thresholds—you must earn below a certain amount to qualify—and require documentation of your financial situation. The application process varies but usually involves submitting income verification documents and a form to the manufacturer or a third-party administrator.

Discount cards are another option to explore. Companies like GoodRx, Walmart, and others offer prescription discount cards that provide negotiated prices at pharmacies. These cards work outside the Medicare system, meaning you don't use your Part D coverage when you use them. In some cases, a discount card price might be lower than your Part D copayment, though this isn't guaranteed. For Rexulti specifically, some discount cards have reported prices ranging from $400 to $800 for a month's supply, compared to your Part D copayment, which could be higher or lower depending on your plan.

It's important to understand that using discount cards means you're not using your Medicare Part D coverage for that particular fill. This affects your cost-sharing stage progression—the pharmacy visit